Introduction:
Remdesivir belongs to nucleoside analogues. It is an RNA dependent RNA polymerase (RdRp) inhibitor, which can inhibit the synthesis of viral nucleic acid. At present, the clinical research on Ebola virus infection has reached phase II. Mice infected with mers performed much better after receiving this combination therapy, with reduced virus replication and improved lung function. Recent studies have shown that Reed Wei Wei has some activity in inhibiting COVID-19.
CAS:1809249-37-3
Molecular formula: C27H35N6O8P
Molecular weight: 602.58
Structural type:
Purpose:
Remdesivir is a new experimental broad-spectrum antiviral drug used to target Ebola virus and is believed to effectively inhibit the replication of SARS virus and MERS virus in respiratory epithelial cells.